NewsRoom Articles - Page 1236 of 1387

TuesdayJun 06, 2017 11:00 am

Moleculin Biotech, Inc. (NASDAQ: MBRX) Starts Presentation at LD Micro 2017 Invitational

Moleculin Biotech (NASDAQ: MBRX) is a preclinical-stage pharmaceutical company that focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in the progression of cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech was founded in 2015 and is headquartered in Houston, Texas. For more information, visit the company's website at…

TuesdayJun 06, 2017 11:00 am

DarioHealth Corp. (NASDAQ: DRIO) Starts Presentation at LD Micro 2017 Invitational

DarioHealth (NASDAQ: DRIO) is a digital health company that develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its flagship product is Dario, a mobile, real-time, cloud-based, diabetes management solution based on a multi-feature software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. The company is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid tests of body fluids using mobile devices and cloud-based services. For more information, visit the…

TuesdayJun 06, 2017 11:00 am

Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at LD Micro 2017 Invitational

Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company that focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company’s lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which has completed pPhase II clinical trials for the treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients. For more information, visit the company's website at www.intecpharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayJun 06, 2017 10:30 am

Ammo, Inc. (POWW) Starts Presentation at LD Micro 2017 Invitational

AMMO (OTC: POWW) is a designer and manufacturer of products for law enforcement, hunting, military, sport shooting and self-defense. Founded in 2016, the company is headquartered in Scottsdale, Arizona, and has a manufacturing facility in Payson, Arizona. Founded with an aim of changing, innovating and invigorating the complacent munitions industry, AMMO promotes branded munitions that include the Jesse James line of munitions and accessories, SHIELD Series munitions for law enforcement, stealth subsonic munitions, and the OPS (One Precise Shot) defense line of munitions. For more information, visit the company’s website at www.ammo-inc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service…

TuesdayJun 06, 2017 10:30 am

BioLargo, Inc. (OTCQB: BLGO) Starts Presentation at LD Micro 2017 Invitational

BioLargo (OTCQB: BLGO) delivers sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. Its BioLargo Water (www.BioLargoWater.com) subsidiary showcases the award-winning Advanced Oxidation Systems, including its AOS Filter -- a product in development specifically designed to quickly and cost-effectively eliminate common yet toxic contaminants in water. BioLargo also owns a 50% interest in the award-winning Isan System. BioLargo's Odor-No-More subsidiary features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies,…

TuesdayJun 06, 2017 10:30 am

inTest (NYSE: INTT) Starts Presentation at LD Micro 2017 Invitational

inTest (NYSE: INTT) designs, manufactures and markets thermal, mechanical and electrical products for use in the testing of integrated circuits (ICs) worldwide. The company operates through two segments: inTEST Thermal Solutions and inTEST Electromechanical Semiconductor Products. The inTEST Thermal Solutions segment offers ThermoStream temperature management tools, MobileTemp systems, ThermoChambers, Thermal Platforms, ThermoChuck precision vacuum platform assemblies, and Thermonics temperature conditioning products. Its products are used to test semiconductor wafers and ICs, electronic components and assemblies, mechanical assemblies, and electromechanical assemblies. For more information, visit the company's website at www.intest.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to…

TuesdayJun 06, 2017 8:30 am

Net Element (NASDAQ: NETE) in the Midst of the Mobile Point-of-Sale Revolution

The process of paying for goods and services is rapidly and radically changing. Virtually unheard of a decade ago, nearly $40 billion in mobile transactions occurred during 2015. Amazingly, that total is expected to explode 20 times to over $800 billion within the next couple of years. During this same time period, the global mobile point-of-sale installed base is projected to grow from about 13 million units to over 54 million units in 2019. A typical mobile point-of-sale solution gives merchants the flexibility to accept credit card payments anywhere and at any time and allows customers to quite literally skip…

MondayJun 05, 2017 8:52 am

ChineseInvestors.com, Inc. (CIIX) Presents Obvious Upside

Archaeological research suggests that Cannabis Sativa, the source plant for cannabidiol (CBD) compounds, was one of the first agricultural crops planted by early man near the birth of agriculture some 10,000 to 12,000 years ago. The use of CBD for health benefits extends back several thousand years as well. CBD is one of more than 80 active cannabinoid chemicals in the Cannabis Sativa (marijuana) plant and is a part of the cannabis plant that does not produce euphoria or a “high”. Anecdotally, CBD has long been considered to have a broad range of medical benefits. Now, two major studies released…

MondayJun 05, 2017 8:00 am

SinglePoint, Inc. (SING) Expands Marijuana Market Reach as Investors Plan for Increased Participation

One of the fastest growing industries in the United States in recent years, the legal marijuana market remains a highly attractive prospect for both entrepreneurs and investors, despite facing uncertain times as a consequence of the new administration’s position on cannabis use. Investors are actually expected to increase their investments this year, determined to push the market toward further growth. A recent GreenWave Advisors report notes that the industry will continue this trend even if the current administration will actively challenge it (http://nnw.fm/2hHRu). Arizona-based holding company SinglePoint, Inc. (OTC: SING) is riding atop the marijuana investing wave, having recently completed…

MondayJun 05, 2017 8:00 am

ABcann Global (TSXV: ABCN) Target Price Set At $2.25 as Coverage is Initiated

Now that shares of ABcann Global Corporation (TSXV: ABCN) are trading on the venture arm of the Toronto Stock Exchange (TSX), the company is creating more buzz than ever. On the same day it launched its initial public offering (IPO) (May 4), industry analysts PI Financial initiated coverage of the stock with a decidedly bullish report (http://nnw.fm/zcgG2) on the company. PI has put a “Buy” rating on the stock and set a one-year price target of $2.25, implying a return of well over 100 percent. The investment bank backs up this sunny prognosis with an in-depth look at ABcann’s value…